ArticleBiotechnology letters2022

A novel property of hexokinase inhibition by Favipiravir and proposed advantages over Molnupiravir and 2 Deoxy D glucose in treating COVID-19.

Prajakta Kulkarni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.